Kourtney Kardashian’s new “GLP-1 Daily” pill is the latest product to capitalize on the weight loss drug craze.

Many people are doing an end-run around their doctor's office, reaching out to potentially unreliable sources that promise to set them up with Wegovy, Zepbound and other weight-loss drugs.

Four key factors can greatly impact how much weight people lose while taking GLP-1 drugs like Ozempic, Wegovy, Victoza, and Saxenda. Here's what to know.

In July, the U.S. Food and Drug Administration warned that people are overdosing on compounded semaglutide injectable products.

The controversy around Ozempic started when celebrities, including Elon Musk, publicly endorsed its use for weight loss, sparking debates over its efficacy and safety outside its primary diabetes management role.

Ozempic is an FDA-approved medication for people who have type 2 diabetes. It’s often prescribed “off-label” for weight loss — when a drug is prescribed for something it’s not approved for.

Weight loss drugs have gone viral. But despite their availability, most people who could benefit from treatments can't access them.

However, the research found that exercising helped preserve bone loss. Experts said that the findings may apply to other GLP-1s, such as semaglutide, the active ingredient in Ozempic. A rapid drop in weight can result in a loss of bone density,